The FSASD Spectrum: Types and Progression

Free Sialic Acid Storage Disease (FSASD) is not a single, fixed condition. Instead, it exists on a phenotypic spectrum—a range of symptom severity that varies from person to person ^[1]. While doctors use specific names like ISSD or Salla disease to describe different points on this spectrum, these are caused by different pathogenic variants within the same SLC17A5 gene. The specific genetic variant, how much residual sialin function remains, and other individual factors all contribute to where a person falls on this spectrum ^[2].

Understanding the spectrum can help you prepare for the road ahead, though it is important to remember that every journey is unique and a person’s phenotype cannot be perfectly predicted by a label alone.

Infantile Free Sialic Acid Storage Disease (ISSD)

ISSD represents the most severe end of the spectrum. It is a multisystem disorder, meaning it affects many parts of the body beyond the brain ^[2].

• When it begins: Symptoms are often present at birth or even before birth (prenatally). Some babies may show nonimmune hydrops fetalis—a serious condition where fluid builds up in the baby’s tissues and organs before birth ^[3][4].
• Key Features: Infants typically have profound hypotonia (very low muscle tone), severe global developmental delays, and distinct facial features ^[5]. They may also have an enlarged liver and spleen (hepatosplenomegaly) and an enlarged heart (cardiomegaly) ^[3][4].
• Progression: Most children with ISSD do not reach major developmental milestones, such as sitting or speaking. Because of the severity of the organ involvement, ISSD is often lethal in early childhood ^[2][4].

Intermediate-Severe Form

This form sits in the middle of the spectrum, with symptoms more severe than classic Salla disease but less life-threatening in early infancy than ISSD ^[5]. Terminology can vary, and doctors may refer to this simply as intermediate FSASD.

• Timeline of Development: Symptoms usually appear within the first six months of life. There may be a period of delayed development where some milestones are gained, such as head control or sitting ^[6][5].
• The Plateau and Regression: In late childhood, development may reach a plateau, where new skills are no longer gained. This can be followed by a slow, progressive neurological regression during adolescence, where skills previously mastered may begin to fade ^[6].
• Physical Features: These individuals often have moderate-to-severe developmental delays and may show some of the distinct facial features seen in ISSD, alongside dystonia (involuntary muscle contractions) ^[5].

Classic Salla Disease

This is the most common and generally the mildest form of the spectrum, though it still involves significant neurological challenges ^[7].

• Early Childhood (Years 1–10): Milestones like sitting and walking may be reached, though often much later than peers. Ataxia (clumsiness or lack of coordination) and nystagmus (involuntary eye movements) are common early signs ^[8][5].
• The Teenage Years: During the teens, the early ataxia may transition into athetotic movements (slow, writhing involuntary motions). Spasticity (stiff or tight muscles) may also become more noticeable during this time ^[7].
• Speech and Communication: While individuals often understand more than they can say, speech production may decline due to dyspraxia (difficulty coordinating the muscles for speech) and dysarthria (slurred or slow speech) ^[7].
• Adulthood: Many individuals with classic Salla disease live into adulthood. A long-term study found that while motor skills may decline after age 20, many patients lived into their 30s, 40s, and beyond, though there is an increased risk of mortality after age 30 ^[7].

Understanding Prognosis

It is difficult to give a precise life expectancy for any individual because the disease is so rare and varied. In a large analysis of 116 published cases across the entire spectrum, the median survival was approximately 11 years ^[1].

However, this number is a mixed-cohort average and is not an individual prediction. It averages babies with ISSD who may only live a few months alongside adults with Salla disease living into their 60s ^[1][7]. Without this context, that 11-year statistic can be alarming and misleading. Individual survival depends heavily on the specific phenotype, genetic variant, and current clinical complications. Your medical genetics team is best equipped to discuss what to expect based on the specific clinical picture.